Anzeige
Mehr »
Samstag, 19.07.2025 - Börsentäglich über 12.000 News
Kupfer en mass...: 10 Prozent-Kupfer an der Oberfläche! - Diese Entdeckung könnte zur heißesten Kupferstory des Jahres werden!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2ACSB | ISIN: KYG3825B1059 | Ticker-Symbol: G51
Frankfurt
18.07.25 | 08:20
1,806 Euro
+0,17 % +0,003
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
GENSCRIPT BIOTECH CORPORATION Chart 1 Jahr
5-Tage-Chart
GENSCRIPT BIOTECH CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
1,7941,86618.07.
1,7781,87718.07.

Aktuelle News zur GENSCRIPT BIOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
GENSCRIPT BIOTECH Aktie jetzt für 0€ handeln
MiGENSCRIPT BIO (01548): VOLUNTARY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES PRELIMINARY SALES FOR CARVYKTI FOR THE QUARTER ENDED 30 JUNE 2025-
09.07.GENSCRIPT BIO (01548): NEXT DAY DISCLOSURE RETURN1
08.07.Exclusive-US lawmakers renew concerns about GenScript's ties to China3
30.06.GENSCRIPT BIO (01548): INSIDE INFORMATION ANNOUNCEMENT - PROBIO RECEIVED PAYMENTS UNDER THE LICENSE AGREEMENT WITH LANOVA MEDICINES LTD.1
11.06.GENSCRIPT BIO (01548): GRANT OF RESTRICTED SHARES2
10.06.GENSCRIPT BIO (01548): NEXT DAY DISCLOSURE RETURN1
04.06.GENSCRIPT BIO (01548): VOLUNTARY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCED NEW 5-YEAR SURVIVAL DATA FOR CARVYKTI IN CARTITUDE-1 STUDY FOR MULTIPLE MYELOMA ...1
29.05.GENSCRIPT BIO (01548): NOMINATION COMMITTEE -TERMS OF REFERENCE2
29.05.GENSCRIPT BIO (01548): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION-
29.05.GENSCRIPT BIO (01548): (1) POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 29 MAY 2025; (2) CHANGE IN COMPOSITION OF THE BOARD; AND (3) CHANGE IN COMPOSITION ...2
23.05.GENSCRIPT BIO (01548): VOLUNTARY ANNOUNCEMENT: LEGEND BIOTECH WILL PRESENT NEW DATA ON CARVYKTI FOR PATIENTS WITH MULTIPLE MYELOMA AT 2025 ASCO AND EHA ...2
16.05.GENSCRIPT BIO (01548): NEXT DAY DISCLOSURE RETURN-
13.05.GENSCRIPT BIO (01548): VOLUNTARY ANNOUNCEMENT: FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2025 OF A LISTED ASSOCIATE - LEGEND BIOTECH CORPORATION-
07.05.GENSCRIPT BIO (01548): COMPLETION OF DISCLOSEABLE TRANSACTION AND TRANSACTION WITH CONNECTED PERSON AT SUBSIDIARY LEVEL IN RELATION TO TRANSFER OF SHARES ...-
28.04.GENSCRIPT BIO (01548): DISCLOSEABLE TRANSACTION AND TRANSACTION WITH CONNECTED PERSON AT SUBSIDIARY LEVEL IN REATION TO TRANSFER OF SHARES OF PROBIO CAYMAN-
23.04.GENSCRIPT BIO (01548): NEXT DAY DISCLOSURE RETURN1
16.04.GENSCRIPT BIO (01548): (REVISED) NEXT DAY DISCLOSURE RETURNS1
15.04.GENSCRIPT BIO (01548): VOLUNTARY ANNOUNCEMENT: LEGEND BIOTECH ANNOUNCES PRELIMINARY SALES FOR CARVYKTI FOR THE QUARTER ENDED 31 MARCH 2025-
14.04.GENSCRIPT BIO (01548): NEXT DAY DISCLOSURE RETURNS1
08.04.GENSCRIPT BIO (01548): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION ...-
Weiter >>
38 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1